Tyrosine Kinase
Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(73)
- Ack1(3)
- Axl(6)
- ALK(64)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(42)
- c-Kit(58)
- c-MET(99)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(278)
- EphB4(1)
- FAK(39)
- FGFR(104)
- FLT3(97)
- HER2(15)
- IGF1R(34)
- Insulin Receptor(46)
- IRAK(32)
- ITK(10)
- Lck(1)
- LRRK2(25)
- PDGFR(113)
- PTKs/RTKs(10)
- Pyk2(8)
- ROR(41)
- Spleen Tyrosine Kinase (Syk)(33)
- Src(108)
- Tie-2 (4)
- Trk(43)
- VEGFR(200)
- Kinase
- Discoidin Domain Receptor(16)
- DYRK(35)
- Ephrin Receptor(13)
- RET(30)
- ROS(14)
- TAM Receptor(33)
- IGFBR(1)
- Others(55)
Tyrosine Kinase 相关产品(1402)
- GC16580LDN-193189CAS: 1062368-24-4纯度: >99.00%
An inhibitor of BMP receptors ALK1, ALK2, ALK3, and ALK6
- GC16712BMS-754807CAS: 1001350-96-4纯度: >99.50% / >98.00%
Dual inhibitor of IGF-1R and InsR tyrosine kinases
- GC16737Gefitinib (ZD1839)CAS: 184475-35-2纯度: >99.50% / >99.00% / >98.00%
吉非替尼(Gefitinib, ZD1839)是一种强效的表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI),IC50为0.033 µM,能选择性抑制表皮生长因子刺激的肿瘤细胞生长,IC50为0.054 µM,并能阻断表皮生长因子刺激的表皮生长因子受体(EGFR)在肿瘤细胞中的自身磷酸化。
- GC168537,8-DihydroxyflavoneCAS: 38183-03-8纯度: >99.50% / >98.00%
7,8-Dihydroxyflavone(7,8-二羟基黄酮)是一种高亲和力酪氨酸激酶受体B(TrkB)激动剂,IC 50 值为0.26μM 。
- GC17137pp60 c-src (521-533) (phosphorylated)CAS: 149299-77-4
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain
- GC17294CHMFL-ABL-053CAS: 1808287-83-3
CHMFL-ABL-053 (Compound 18a) 是一种有效的、选择性的、可口服的 BCR-ABL、SRC 和 p38 激酶抑制剂,对 ABL1、SRC 和 p38 的 IC50 值分别为 70、90 和 62 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16244 | Icotinib Hydrochloride | 1204313-51-8 | >99.50% | |
An EGFR inhibitor | ||||
| GC16321 | EGF816 | 1508250-71-2 | >99.00% | |
An inhibitor of mutant EGFR | ||||
| GC16421 | Cediranib (AZD217) | 288383-20-0 | >99.50% | |
An inhibitor of VEGF receptor tyrosine kinases | ||||
| GC16483 | MAZ51 | 163655-37-6 | >98.00% | |
MAZ51是一种选择性血管内皮生长因子受体3(VEGFR-3;FLT4)酪氨酸激酶抑制剂。 | ||||
| GC16499 | Sorafenib Tosylate | 475207-59-1 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC16519 | ENMD-2076 | 934353-76-1 | >98.00% | |
A multi-kinase inhibitor | ||||
| GC16580 | LDN-193189 | 1062368-24-4 | >99.00% | |
An inhibitor of BMP receptors ALK1, ALK2, ALK3, and ALK6 | ||||
| GC16604 | Altiratinib | 1345847-93-9 | >98.00% | |
A multiple kinase inhibitor | ||||
| GC16694 | TAE684 (NVP-TAE684) | 761439-42-3 | >99.00% | |
A selective ALK inhibitor | ||||
| GC16712 | BMS-754807 | 1001350-96-4 | >99.50% / >98.00% | |
Dual inhibitor of IGF-1R and InsR tyrosine kinases | ||||
| GC16731 | CZC 54252 hydrochloride | 1191911-27-9 | >99.00% | |
An LRRK2 inhibitor | ||||
| GC16737 | Gefitinib (ZD1839) | 184475-35-2 | >99.50% / >99.00% / >98.00% | |
吉非替尼(Gefitinib, ZD1839)是一种强效的表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI),IC50为0.033 µM,能选择性抑制表皮生长因子刺激的肿瘤细胞生长,IC50为0.054 µM,并能阻断表皮生长因子刺激的表皮生长因子受体(EGFR)在肿瘤细胞中的自身磷酸化。 | ||||
| GC16798 | LDN-211904 | 1198408-78-4 | >98.00% | |
An EphB3 kinase inhibitor | ||||
| GC16813 | Defactinib | 1073154-85-4 | >98.00% / >99.50% | |
A FAK inhibitor | ||||
| GC16853 | 7,8-Dihydroxyflavone | 38183-03-8 | >99.50% / >98.00% | |
7,8-Dihydroxyflavone(7,8-二羟基黄酮)是一种高亲和力酪氨酸激酶受体B(TrkB)激动剂,IC 50 值为0.26μM 。 | ||||
| GC16957 | Src I1 | 179248-59-0 | >99.50% | |
A potent inhibitor of Src kinases | ||||
| GC17024 | DMPQ dihydrochloride | 1123491-15-5 | - | |
An potent inhibitor of PDGFRβ | ||||
| GC17098 | DMH4 | 515880-75-8 | - | |
A VEGFR2 inhibitor | ||||
| GC17137 | pp60 c-src (521-533) (phosphorylated) | 149299-77-4 | - | |
Peptide corresponding to the pp60c-src carboxy terminal regulatory domain | ||||
| GC17294 | CHMFL-ABL-053 | 1808287-83-3 | - | |
CHMFL-ABL-053 (Compound 18a) 是一种有效的、选择性的、可口服的 BCR-ABL、SRC 和 p38 激酶抑制剂,对 ABL1、SRC 和 p38 的 IC50 值分别为 70、90 和 62 nM。 | ||||
| GC17323 | FIIN-2 | 1633044-56-0 | >99.50% | |
An FGFR inhibitor | ||||
| GC17369 | Sorafenib | 284461-73-0 | >99.50% / >99.00% | |
索拉非尼Sorafenib是Raf-1和B-Raf的多激酶抑制剂,IC50分别为6 nM和22 nM;Sorafenib对VEGFR-2 VEGFR-3 PDGFR-β Flt-3和c-KIT也有抑制作用,IC50值分别为90 nM、20 nM、57 nM、59 nM和68 nM;索拉非尼能诱导自噬细胞凋亡和激活铁死亡,并具有抗肿瘤活性。 | ||||
| GC17376 | ALK inhibitor 2 | 761438-38-4 | >99.50% | |
An inhibitor of TSSK2 | ||||
| GC17489 | AG 494 | 133550-35-3 | >99.00% | |
An inhibitor of EGF receptor kinase | ||||
